论文部分内容阅读
目的对黄体酮治疗黄体功能不全所致先兆流产的临床疗效进行分析。方法 84例黄体功能不全所致先兆流产患者,随机分为观察组和对照组,各42例。对照组给予保胎灵胶囊治疗,观察组给予黄体酮口服治疗,比较两组效果。结果对照组治疗成功率为66.7%,不良反应发生率为14.3%;观察组分别为92.9%、9.5%;观察组成功率显著高于对照组,差异有统计学意义(P<0.05),不良反应发生率与对照组比较差异无统计学意义(P>0.05)。治疗后两组β-人绒毛膜促性腺激素(β-HCG)水平均显著高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05)。结论黄体酮对黄体功能不全所致先兆流产孕妇有良好效果,用药安全可靠,值得临床推广。
Objective To analyze the clinical efficacy of progesterone in the treatment of threatened abortion caused by luteal insufficiency. Methods Eighty-four patients with threatened abortion due to luteal insufficiency were randomly divided into observation group and control group, with 42 cases in each group. The control group was given Baoling capsule treatment, the observation group was given progesterone oral treatment, the two groups were compared. Results The success rate of treatment in control group was 66.7%, the incidence of adverse reactions was 14.3%; the observation group was 92.9% and 9.5% respectively; the success rate of observation group was significantly higher than that of control group (P <0.05) There was no significant difference in incidence between the two groups (P> 0.05). The levels of β-HCG in the two groups after treatment were significantly higher than those before treatment, and the observation group was higher than the control group, the difference was statistically significant (P <0.05). Conclusions Progesterone has a good effect on pregnant women with threatened abortion caused by corpus luteum insufficiency, which is safe and reliable and worthy of clinical promotion.